Rare diseases are defined as conditions that affect fewer than 1:2,000 people; however, as a group of conditions they are quite common, affecting 1 in 17 individuals, which in the UK equates to 3.5 million people. Mutations in genes encoding the extracellular matrix components, cell-matrix adhesion complexes and signalling pathways are all implicated in rare disease. Moreover, rare diseases share common molecular mechanisms that can be targeted in order to find affordable treatments that can be applicable to common diseases and age-related conditions as well.
The meeting is hosted by Dr Katarzyna Pirog from the University of Newcastle.
Speakers include:
Inês Alves (ANDO, Portugal)
Matt Warman (Harvard University, USA)
Brendan Lee (Baylor College of Medicine, USA)
Francesco Ramirez (Mount Sinai, USA)
Su Lwin (King’s College London, UK)
Alison Gartland (Sheffield University, UK)
Rachel Lennon (Manchester University, UK)
James Gallagher (University of Liverpool, UK)
© 2024 British Society for Matrix Biology. All rights reserved.